Vaxart, Inc.
Datakwaliteit: 100%
VXRT
OTC
Manufacturing
Chemicals
€ 0,63
€ 0,00
(0,00%)
Marktkapitalisatie: 152,09 M
Prijs
€ 0,63
Marktkapitalisatie
152,09 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—
Quick Summary
Belangrijkste Punten
ROE of 54,76% indicates high profitability
Generating 7,57 M in free cash flow
P/E of 9,32 — trading at a low valuation
Capital efficient — spends only 0,06% of revenue on capex
ROIC of 40,89% — excellent capital efficiency
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)726,68%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
54,76%
Boven sectorgemiddelde (-54,47%)
ROIC40,89%
Net Margin6,88%
Op. Margin7,62%
Veiligheid
Debt / Equity
N/A
Current Ratio0,69
Interest CoverageN/A
Waardering
PE (TTM|NTM)
9,32 | -0,94
Boven sectorgemiddelde (-1,49)
P/B Ratio5,68
EV/EBITDA4,63
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1385 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1385 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 9,3 | -1,5 |
| P/B | 5,7 | 1,6 |
| ROE % | 54,8 | -54,5 |
| Net Margin % | 6,9 | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
Koersdoel Analisten
2 analisten
Buy
Huidig
€ 0,63
Koersdoel
€ 3,00
€ 2,00
€ 3,00
€ 4,00
Vooruitzicht
Forward K/W
-0,94
Forward WPA
-€ 0,67
Omzet Sch.
1,13 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
-€ 0,67
-€ 0,67 – -€ 0,67
|
1,13 M | 1 |
| FY2026 |
-€ 0,54
-€ 0,54 – -€ 0,54
|
355,90 M | 1 |
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| 2026 Q2 |
-€ 0,03
-€ 0,03 – -€ 0,03
|
50,50 M | 1 |
| 2026 Q1 |
€ 0,02
€ 0,02 – € 0,02
|
65,50 M | 1 |
Winstverassingen
Laatste 4 kwartalen
| Kwartaal | Geschat WPA | Werkelijk WPA | Verrassing |
|---|---|---|---|
| Q42025 | -€ 0,08 | € 0,24 | +400,0% |
| Q32025 | -€ 0,07 | -€ 0,04 | +38,5% |
| Q22025 | -€ 0,10 | -€ 0,07 | +26,3% |
| Q12025 | -€ 0,07 | -€ 0,07 | 0,0% |
Dividend History
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Nov 09, 2012 | — | € 12,19 | N/A |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 726,68% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 237,26 M | Net Income (TTM) | 16,33 M |
| ROE | 54,76% | ROA | 8,75% |
| Gross Margin | N/A | Operating Margin | 7,62% |
| Net Margin | 6,88% | Free Cash Flow (TTM) | 7,57 M |
| ROIC | 40,89% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,69 |
| Interest Coverage | N/A | Asset Turnover | 1,27 |
| Working Capital | -51,93 M | Tangible Book Value | 19,24 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | 1 yrs | ||
| Valuation | |||
| P/E Ratio | 9,32 | Forward P/E | -0,94 |
| P/B Ratio | 5,68 | P/S Ratio | 0,64 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | 4,63 | Fwd EV/EBITDA | N/A |
| Forward P/S | 134,77 | Fwd Earnings Yield | N/A |
| FCF Yield | 4,98% | ||
| Market Cap | 152,09 M | Enterprise Value | 123,29 M |
| Per Share | |||
| EPS (Diluted TTM) | 0,07 | Revenue / Share | 0,98 |
| FCF / Share | 0,03 | OCF / Share | 0,03 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 0,06% | FCF Conversion | 46,36% |
| SBC-Adj. FCF | -1,50 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 237,26 M | 28,70 M | — | — | — |
| Net Income | 16,33 M | -66,95 M | -82,47 M | -107,76 M | -70,47 M |
| EPS (Diluted) | 0,07 | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | 18,07 M | -66,29 M | -83,35 M | -114,59 M | -72,75 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 201,58 M | 74,21 M | 68,14 M | 81,05 M | 48,75 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 8,58 M | 8,85 M | 8,62 M | 5,81 M | 4,21 M |
| Interest Expense | — | — | — | — | 0,0 |
| Income Tax | 476.000,0 | 260.000,0 | 261.000,0 | 67.000,0 | 107.000,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 186,08 M | 166,39 M | 91,83 M | 153,85 M | 221,17 M |
| Total Liabilities | 98,28 M | 107,46 M | 34,03 M | 43,25 M | 33,64 M |
| Shareholders' Equity | 87,80 M | 58,93 M | 57,81 M | 110,60 M | 187,53 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 63,80 M | 51,70 M | 34,76 M | 44,01 M | — |
| Current Assets | 136,12 M | 68,26 M | 45,54 M | 99,45 M | 169,17 M |
| Current Liabilities | 86,75 M | 90,88 M | 13,72 M | 17,92 M | 10,78 M |
{"event":"ticker_viewed","properties":{"ticker":"VXRT","listing_kind":"stock","pathname":"/stocks/vxrt","exchange":"OTC","country":"US"}}